Mobile Technology for Reducing and Preventing Adolescent Suicide

Hartford Hospital

Status

Completed

Conditions

Suicide, Attempted

Suicidal Ideation

Treatments

Behavioral: Smartphone App

Study type

Interventional

Funder types

Other

Industry

NIH

Identifiers

NCT04896593

HHC-2020-0363

R43MH125691 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This single-group open-label trial will evaluate the feasibility and preliminary efficacy of a suicide prevention mobile application when used as an adjunct to usual care in adolescents.

Full description

This study will enroll 20 adolescent (age 13-17) inpatients at elevated risk for suicide. Participants will download the app onto their phones during their inpatient stay and will complete a single therapy session involving psychoeducation and crisis response planning. Participants will be encouraged to use the app on their own in addition to their usual outpatient services to learn and practice suicide prevention skills. Participants and their parents will be interviewed 1, 4, 8, 12, and 16 weeks after discharge.

Enrollment

22 patients

Sex

All

Ages

13 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Inpatient psychiatric patients who have attempted suicide (lifetime) or have documented suicide ideation and a plan to harm themselves at admission
Understand written and spoken English
Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
Willing and able to complete enrollment procedures
Parent/guardian (and youth) able to understand the nature of the study and provide written informed consent (assent for youth)
Willing to agree to release of information to their parent/guardian and providers when clinically indicated.
Discharge plan includes aftercare within the Hartford HealthCare system (to facilitate coordination of care during follow up)

Exclusion criteria

Patients with active psychosis
Patients experiencing substance withdrawal
Currently enrolled in other treatment studies for the symptoms and behaviors targeted
Patient unwilling or unable to wear mask during in-person study procedures
Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit profile with respect to the Smartphone App.
Any other psychiatric or medical condition (e.g., intellectual disability) or custody arrangement that in the investigator's opinion would preclude informed consent/assent or participation in the trial.